Navigation Links
Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
Date:11/23/2009

ALISO VIEJO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International (NYSE: VRX), today announced that it has now launched chlordiazepoxide hydrochloride and clidinium bromide, an authorized generic (AG) version of Librax®. Oceanside has received its first orders and expects to be a significant player in the Librax® generic market.

"Valeant's Oceanside unit has become an important division of our U.S. business with its successful launch and distribution of 5% fluorouracil, Valeant's authorized generic of Efudex®," stated J. Michael Pearson, chairman and chief executive officer. "Oceanside currently maintains a 55% market share of its Efudex® AG and plans to retain this leadership position in the future. With the industry experience we have had with Efudex® AG, we believe that we can successfully grow a strong market position with the launch of Librax® AG."

About Valeant

Valeant Pharmaceuticals International (NYSE: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology and dermatology. More information about Valeant can be found at www.valeant.com.

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements, including, but not limited to, statements regarding Oceanside's launch and growth of Librax AG and Oceanside's strong leadership position with Efudex AG. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "shoul
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... SAN DIEGO , Aug. 26, 2014 /PRNewswire/ ... Sorrento), a late-stage clinical oncology company developing new ... announced that it has received funding to advance ... the potential treatment of IPF, which affects more ... in the lungs increases and patients gradually lose ...
(Date:8/26/2014)... SAN FRANCISCO , Aug. 26, 2014    ... health record (EHR) platform , today announced the addition ... as the company,s chief commercial officer and Joe ... partnerships. On the heels of Practice Fusion,s recent hire ... marks a further expansion of the company,s executive bench. ...
(Date:8/26/2014)... 2014 MNX Global Logistics, Medical Device ... a multi-year contract providing time- and mission-critical logistics ... device company in the world. The precision and ... well suited to MNX,s main business competencies. MNX,s ... a surgeon, surgical team and patient, who rely ...
Breaking Medicine Technology:Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 2Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF) 3Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 2Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 3MNX Global Logistics renews multi-year contract with NuVasive, Inc. 2
... 2011 I-Flow , a Kimberly-Clark Health ... agreement with Buffalo Supply, Inc. (BSI), whereby its ... available on Buffalo Supply,s Federal Supply Schedule. These ... Catheters, ON-Q® SilverSoaker Antimicrobial Catheters with SilvaGard and ...
... Aug. 2, 2011 Cardium Therapeutics (NYSE Amex: ... 510(k) application seeking clearance from the U.S. Food and ... topical wound care management medical device comprising 2.6% formulated ... dermal wounds.  In addition to diabetic foot ulcers, dermal ...
Cached Medicine Technology:I-Flow Corporation Enters into Exclusive Government Distribution Agreement With Buffalo Supply, Inc. 2Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans 2Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans 3Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans 4Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans 5
(Date:8/27/2014)... 27, 2014 Janice Holly Booth ... when no-one would join her on an adventure outing to ... extreme sport involving ropes, harnesses and rappelling into mysterious, dark ... solo travel but definitely not my last,” she says. “I ... pushed me to the edge, and experienced first-hand the kind ...
(Date:8/27/2014)... 2014 The Connecticut Community for Addiction Recovery ... 19, 2014, from 10:00 AM – 2:00 PM in Bushnell ... from participants across the state to show their support for ... Connecticut’s state capitol. , Recovery Walks! is a celebration for ... alcohol and other drugs as well as their families, friends, ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Hearing aids ... can be hard for plan holders to determine what their ... now participating in several additional health plans and has published ... financial assistance page . , The following is a ... is a participating provider: , NYSHIP/ NYS Empire Plan - ...
(Date:8/26/2014)... 27, 2014 Emerging and established leaders ... useful to those they serve – which includes their ... at http://www.PerWickstrom.com and read his latest must-read ... Maintain their Edge.” , “Leadership is not ... can therefore be assumed,” commented Per Wickstrom, who blogs ...
(Date:8/26/2014)... August 27, 2014 There are a ... however the reality is cruel. Some people, especially ladies ... may not save enough money to be affluent. Today, ... delighted to announce its new catalog, Flash Deals (also ... bags, outdoor accessories and more from this company are ...
Breaking Medicine News(10 mins):Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Per Wickstrom’s Latest Blog Post Provides 10 Tips to Help Leaders Maintain their Edge 2Health News:Become a Rich Person Right Away By Taking Advantage Of Fecbek.com's Flash Deals 2
... Pa., April 27 Universal Health Services, Inc. (NYSE: ... $67.5 million, or an increase of 14% to $1.37 per ... to $61.7 million, or $1.20 per diluted share, during the ... million, or an increase of 17% to $1.37 per diluted ...
... to Mexico City BALTIMORE, April 27 With 40 ... in the U.S., top officials declared a national health ... Lessans, CEO of Passport Health, the nation,s largest provider ... travelers to postpone their trips to Mexico City and, ...
... Center for Disease Control and Prevention has confirmed ... virus in the United States and the World ... health emergency of international concern." As the swine ... emergency rooms prepare to accommodate patients with symptoms ...
... - First and Only Topical Gel for OAB to ... Data to be presented at the American Urological Association,s ... gel significantly improves symptoms of OAB and urinary urge ... end of the 12-week study period, 27 percent of ...
... Two reports show promise of computers, pharmacists for proper ... errors and adverse drug reactions cost lives and dollars ... reports suggest ways hospitals and pharmacists can work to ... the most common medical errors, affecting at least 1.5 ...
... More than 3,000 long-term care professionals ... the Midwest,s largest gathering of personnel from skilled nursing ... disabled population. The Ohio Health Care Association (OHCA), which ... the state, is hosting its 63rd Annual Convention & ...
Cached Medicine News:Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 2Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 3Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 4Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 5Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 6Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 7Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 8Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 9Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 10Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 11Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 12Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 13Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 14Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 15Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 16Health News:Universal Health Services, Inc. Reports 17% Increase in 2009 First Quarter Earnings from Continuing Operations Per Diluted Share 17Health News:Swine Flu Spreads 2Health News:Copan Diagnostics, Inc. Offers Kit for Rapid Collection of Nasopharyngeal Sample to Detect Swine Flu Virus 2Health News:New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients 2Health News:New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients 3Health News:New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients 4Health News:Medication Errors Could Be Cut: Experts 2Health News:Medication Errors Could Be Cut: Experts 3Health News:Medication Errors Could Be Cut: Experts 4Health News:Ohio Health Care Association/Ohio Centers for Assisted Living Host Midwest's Largest Long-Term Care Convention in Columbus 2
Provides a combination of concentrated cold / hot and compression for the back...
... One-Piece™ Collar is completely injected molded from ... our patented chin support. , ,Our ... efficiently managed where space is limited. Color-coded ... of sizes., ,Either in a supine ...
... therapy Gel Pad. Our Gel Pad helps defeat ... reduce swelling and /or hot therapy to increase ... hot and cold therapy gel pad, place an ... can be added to each support upon request. ...
... Because when it comes to superior immobilization ... do the job., ,You already know that ... is immobilization of the c-spine. But what you ... that Jerome Medical's NECLOC ®: provides superior immobilization ...
Medicine Products: